In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

PURPOSE: To test a reduced version—CIPN15—of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy scale (QLQ-CIPN20) to establish a possible gold-standard patient-reported outcome measure for chemotherapy-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Ellen M. Lavoie, Knoerl, Robert, Yang, James J., Kanzawa-Lee, Grace, Lee, Deborah, Bridges, Celia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925747/
https://www.ncbi.nlm.nih.gov/pubmed/29480026
http://dx.doi.org/10.1177/1073274818756608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925747/
https://www.ncbi.nlm.nih.gov/pubmed/29480026
http://dx.doi.org/10.1177/1073274818756608

Ejemplares similares